Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06583408 · ClinicalTrials.gov registry record
The REgistry of Very Early Estrogen and AnovuLation
A clinical trial of Hypothalamic Amenorrhea and Hypothalamic Amenorrhea, Functional, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 2
- Study locations
NCT06583408: Recruiting study of Hypothalamic Amenorrhea and Hypothalamic Amenorrhea, Functional, sponsored by Mayo Clinic.
NCT06583408 is a study of Hypothalamic Amenorrhea and Hypothalamic Amenorrhea, Functional that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100,000 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06583408, a study of Hypothalamic Amenorrhea and Hypothalamic Amenorrhea, Functional, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
Primary Outcome
Establish and maintain a comprehensive registry of patients diagnosed with Functional Hypothalamic Amenorrhea (FHA). This registry will include detailed demographic information, clinical data, and longitudinal follow-up to track the prevalence, underlying causes, risk factors, and prognosis of FHA. It will also facilitate the collection of data on racial and ethnic disparities, lifestyle factors, psychological stressors, hormonal imbalances, and the impact of various treatment interventions on l
Conditions Studied
Interventions
- OTHER Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)
- OTHER REVEAL Questionnaire
Study Locations (2)
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2029-08-01 |
What NCT06583408 shows while recruiting
NCT06583408 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 3 conditions, with Hypothalamic Amenorrhea appearing as the primary indexed condition, and to 2 interventions - of which Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24) is the first listed.
NCT06583408 reports a single indexed study location in Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06583408 about?
NCT06583408 is a clinical study titled "The REgistry of Very Early Estrogen and AnovuLation". The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
What is the current status of trial NCT06583408?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2024-07-01. Estimated completion is 2029-08-01.
What conditions does trial NCT06583408 study?
This clinical trial studies the following conditions: Hypothalamic Amenorrhea, Hypothalamic Amenorrhea, Functional, Functional Hypogonadotropic Hypogonadism.
What interventions are being tested in trial NCT06583408?
The interventions under investigation include: Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24) (OTHER), REVEAL Questionnaire (OTHER).
Who is sponsoring clinical trial NCT06583408?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06583408 being conducted?
This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothalamic Amenorrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI